-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
December is the end of the year, but the wave of resignations in the pharmaceutical industry continues.
Just recently, two more pharmaceutical company chairmen rushed to the "last train" in 2021, and the news of their resignation came out
.
Chairman of Guang Yuyuan resigns On the evening of December 6, Guang Yuyuan issued an announcement stating that Mr.
Zhang Bin had applied for resignation as chairman of the company due to job changes.
According to relevant regulations, Zhang Bin’s resignation report was delivered to the company’s board of directors.
Effective, after resignation, Zhang Bin will still serve as director and president of the company
.
In addition, Ju Zhen was elected as the chairman of the company's seventh board of directors, and his term of office is until the expiration of the current board of directors
.
Public information, Zhang Bin, a former assistant general manager of Xi'an Topsun Group Co.
, Ltd.
, general manager of Shaanxi Dongsheng Pharmaceutical Co.
, Ltd.
medicine far wide reputation director, vice president, president and other positions
.
It is worth mentioning that at the meeting, Shennong Technology's proposal to nominate Ju Zhen, Li Xiaojun and Liu Zhaowei as candidates for the seventh board of directors was also passed at the second extraordinary general meeting of shareholders in 2021
.
This means that Guangyuyuan’s controlling shareholder Shennong Technology has formally taken over Guangyuyuan
.
Affected by this news, Guangyuyuan's stock price rose rapidly on December 7, and quickly hit the daily limit
.
According to the company's third quarter report for 2021, Guangyuyuan achieved operating income of 595 million yuan in the first three quarters, a year-on-year decrease of 13.
42%, and a net profit loss attributable to shareholders of listed companies was 111 million yuan, a year-on-year decrease of 270.
77%
.
Chairman of China Resources Sanjiu resigns On December 3, China Resources Sanjiu issued an announcement stating that the board of directors received a resignation report from Chairman Wang Chuncheng.
Due to job changes, Wang Chuncheng proposed to resign as chairman and director.
After resignation, he no longer works.
The company holds a position
.
As of the date of this announcement, Mr.
Wang Chuncheng does not hold any shares of the company
.
According to public information, Wang Chuncheng has joined China Resources Group for more than 20 years and has served as Deputy General Manager and General Manager of the Personnel Department of China Resources Co.
, Ltd.
, Assistant General Manager of China Resources Co.
, Ltd.
, and Deputy General Manager of the Office of the Executive Board of China Resources (Group) Co.
, Ltd.
, General manager and other positions
.
The current deputy general manager of China Resources Group and the chairman of the board of directors of China Resources Pharmaceutical Group Co.
, Ltd.
.
From the perspective of financial data, China Resources Sanjiu is currently under certain performance pressure.
The company's 2021 third quarter report shows that during the reporting period, it achieved operating income of 3.
343 billion yuan, a year-on-year decrease of 2.
7%; net profit of 376 million yuan, a year-on-year decrease of 28.
57%
.
In the second half of the year, in addition to China Resources Sanjiu and Guang Yuyuan, the chairman of many pharmaceutical companies resigned.
In the second half of the year, the chairman of many pharmaceutical companies also resigned.
For example, on November 12, First Pharmaceutical issued an announcement saying that Ms.
Xu Ziying was due to work reasons , Apply to resign from the company's 9th Board of Directors, Directors, Chairman of the Strategic Committee of the Board of Directors, and members of the Remuneration and Appraisal Committee
.
After resignation, Ms.
Xu Ziying ceased to hold any position in the company; on November 1, Ruizhi Pharmaceutical issued an announcement stating that Mr.
WOOSWEELIAN had applied for resignation from the company's chairman, director, and chairman of the board's strategy committee due to personal reasons, and continued to serve as the company's strategic consultant after resignation
.
The analysis believes that under the general medical reform environment such as centralized procurement and medical insurance, the changes of senior management of pharmaceutical companies have become very frequent.
There are many positions such as chairman, general manager, and president.
It is expected that the changes of senior management of pharmaceutical companies may continue in the next period of time.
.
Just recently, two more pharmaceutical company chairmen rushed to the "last train" in 2021, and the news of their resignation came out
.
Chairman of Guang Yuyuan resigns On the evening of December 6, Guang Yuyuan issued an announcement stating that Mr.
Zhang Bin had applied for resignation as chairman of the company due to job changes.
According to relevant regulations, Zhang Bin’s resignation report was delivered to the company’s board of directors.
Effective, after resignation, Zhang Bin will still serve as director and president of the company
.
In addition, Ju Zhen was elected as the chairman of the company's seventh board of directors, and his term of office is until the expiration of the current board of directors
.
Public information, Zhang Bin, a former assistant general manager of Xi'an Topsun Group Co.
, Ltd.
, general manager of Shaanxi Dongsheng Pharmaceutical Co.
, Ltd.
medicine far wide reputation director, vice president, president and other positions
.
It is worth mentioning that at the meeting, Shennong Technology's proposal to nominate Ju Zhen, Li Xiaojun and Liu Zhaowei as candidates for the seventh board of directors was also passed at the second extraordinary general meeting of shareholders in 2021
.
This means that Guangyuyuan’s controlling shareholder Shennong Technology has formally taken over Guangyuyuan
.
Affected by this news, Guangyuyuan's stock price rose rapidly on December 7, and quickly hit the daily limit
.
According to the company's third quarter report for 2021, Guangyuyuan achieved operating income of 595 million yuan in the first three quarters, a year-on-year decrease of 13.
42%, and a net profit loss attributable to shareholders of listed companies was 111 million yuan, a year-on-year decrease of 270.
77%
.
Chairman of China Resources Sanjiu resigns On December 3, China Resources Sanjiu issued an announcement stating that the board of directors received a resignation report from Chairman Wang Chuncheng.
Due to job changes, Wang Chuncheng proposed to resign as chairman and director.
After resignation, he no longer works.
The company holds a position
.
As of the date of this announcement, Mr.
Wang Chuncheng does not hold any shares of the company
.
According to public information, Wang Chuncheng has joined China Resources Group for more than 20 years and has served as Deputy General Manager and General Manager of the Personnel Department of China Resources Co.
, Ltd.
, Assistant General Manager of China Resources Co.
, Ltd.
, and Deputy General Manager of the Office of the Executive Board of China Resources (Group) Co.
, Ltd.
, General manager and other positions
.
The current deputy general manager of China Resources Group and the chairman of the board of directors of China Resources Pharmaceutical Group Co.
, Ltd.
.
From the perspective of financial data, China Resources Sanjiu is currently under certain performance pressure.
The company's 2021 third quarter report shows that during the reporting period, it achieved operating income of 3.
343 billion yuan, a year-on-year decrease of 2.
7%; net profit of 376 million yuan, a year-on-year decrease of 28.
57%
.
In the second half of the year, in addition to China Resources Sanjiu and Guang Yuyuan, the chairman of many pharmaceutical companies resigned.
In the second half of the year, the chairman of many pharmaceutical companies also resigned.
For example, on November 12, First Pharmaceutical issued an announcement saying that Ms.
Xu Ziying was due to work reasons , Apply to resign from the company's 9th Board of Directors, Directors, Chairman of the Strategic Committee of the Board of Directors, and members of the Remuneration and Appraisal Committee
.
After resignation, Ms.
Xu Ziying ceased to hold any position in the company; on November 1, Ruizhi Pharmaceutical issued an announcement stating that Mr.
WOOSWEELIAN had applied for resignation from the company's chairman, director, and chairman of the board's strategy committee due to personal reasons, and continued to serve as the company's strategic consultant after resignation
.
The analysis believes that under the general medical reform environment such as centralized procurement and medical insurance, the changes of senior management of pharmaceutical companies have become very frequent.
There are many positions such as chairman, general manager, and president.
It is expected that the changes of senior management of pharmaceutical companies may continue in the next period of time.
.
